StockData
Pharvaris N.V. logo

Pharvaris N.V. (PHVS) stock

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30
$33.36−0.47 (-1.39%)

Close on Nov 13, 2026Market cap $2.18BP/E –Yield –

Pharvaris pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Pharvaris

Pharvaris has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Pharvaris figures

See a number that looks wrong?